Advocates argue that anti-obesity drugs like Ozempic could help overweight troops, but the services have no uniform policy ...

A University of Alberta pharmacology researcher has discovered that a new experimental anti-obesity drug improves diastolic ...

What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...

Allowing Medicare to cover anti-obesity medications would drive up federal spending by about $35 billion on net between 2026 and 2034, according to ...

Goldman Sachs Research predicts the global anti-obesity drug market could reach $100 billion by ... a whopping 66% of ...

Experts reevaluate coverage policies and the financial impact of antiobesity medications based on updated clinical data and ...

I don’t think suddenly we’ve got X amount of unemployed people and we all give them Mounjaro and once they start losing ...

Researchers said the drugs don’t appear to raise the risk of suicidal thoughts or actions for young people but also urged ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.View on ...

New-generation anti-obesity drug Wegovy, made by the same company that created Ozempic, is now available in France – but it ...

Like many health plans, Lilla’s insurance didn’t cover Wegovy for weight loss use. Out of pocket, a month’s supply came with a price tag of more than $1,300. Even after applying a coupon from the drug ...

Noom Med with SmartRx, in partnership with Waltz Health, drives significant ROI for employers who wish to cover GLP-1s as a supplemental benefit ...